Abstract:TORC1 is a highly conserved kinase complex in eukaryotes that regulates cellular metabolism and growth by sensing signals such as nutrients, growth factors, and energy levels. Dysregulation of the TORC1 signaling pathway has been associated with metabolic disorders, neurodegenerative diseases, cancer, and aging. In this review, we compare the structure and function of TORC1 in yeast and mammalian cells. TORC1 in yeast consists of Tor1/Tor2, Kog1, Lst8, and Tco89, while mTORC1 in mammalian consists of mTOR (homolog of yeast TOR1/2), RAPTOR (homolog of yeast Kog1), mLST8 (homolog of yeast Lst8), PRAS40 and DEPTOR. We then review the critical roles of phosphorylation and ubiquitination in transducing external signals to TORC1 and regulating the downstream signaling pathways. Yeast TORC1 phosphorylates and activates Sch9 and Ypk3 to promote protein translation. Yeast TORC1 also regulates stress response, nitrogen metabolism, and autophagy by phosphorylating and inhibiting Tap42, Atg13, and Npr1. Mammalian AMPK, CK1 alpha, Rheb, and AKT can phosphorylate mTORC1, thereby regulating the activity of mTORC1. mTORC1 regulates protein and lipid metabolism by phosphorylating downstream effector proteins, including S6K1, 4E-BP1, and LIPIN1. mTORC1 also inhibits autophagy by phosphorylating ULK1, TFEB, and ATG13. In addition, E3 ubiquitin ligases, including RNF167, RNF186, SCF, etc., either cause protein degradation or promote protein interactions through different forms of polyubiquitination, thus precisely modulating the mTORC1 signaling pathways. The crosstalk between phosphorylation and ubiquitination involved in the mTORC1 signaling pathway is also summarized. An in-depth understanding of the effects of phosphorylation and ubiquitination on the TORC1 signaling pathway can provide new insights for drug target discovery.

Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

Regulatory Function of Phosphorylation and Ubiquitination on The TORC1 Signaling Pathway

Supplementary Methods and Figures Legends from FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K–AKT Pathway

Molecular and Cellular Pathobiology FoxO Transcription Factors Promote AKT Ser 473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI 3 K – AKT Pathway

A Subset of Metastatic Pancreatic Ductal Adenocarcinomas Depends Quantitatively on Oncogenic Kras/Mek/Erk-Induced Hyperactive Mtor Signalling

I Kappa B Kinase Epsilon And Tank-Binding Kinase 1 Activate Akt By Direct Phosphorylation

Cross-talk between Sirtuin and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in the Regulation of S6 Kinase 1 (S6K1) Phosphorylation

S6K1-mediated Phosphorylation of PDK1 Impairs AKT Kinase Activity and Oncogenic Functions

SIN1/MIP1 Maintains Rictor-Mtor Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity

PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress.

mTORC3 activity is regulated by GSK3β through the activation of PKCδ that phosphorylates and activates STAT1

Inhibition of Rb Phosphorylation Leads to Mtorc2-Mediated Activation of Akt

Tyrosine phosphorylation of DEPTOR functions as a molecular switch to activate mTOR signaling

The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

Dual Phosphorylation of Sin1 at T86 and T398 Negatively Regulates Mtorc2 Complex Integrity and Activity

Sin1 Phosphorylation Impairs Mtorc2 Complex Integrity and Inhibits Downstream Akt Signalling to Suppress Tumorigenesis

The PTEN–PI3K Axis in Cancer

Targeting the PI3K pathway in cancer: are we making headway?

Pyruvate Kinase M2 Activates Mtorc1 by Phosphorylating AKT1S1.

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

The Mammalian Target of Rapamycin Complex 2 Controls Folding and Stability of Akt and Protein Kinase C